| Hazard Ratio | 95%CI | p Value |
---|---|---|---|
Univariable analysis | |||
 Age | 1.030 | 1.008–1.053 | 0.009 |
 APACHEII | 1.087 | 1.050–1.125 | < 0.001 |
 SOFA | 1.202 | 1.089–1.327 | < 0.001 |
 NE dose | 1.897 | 1.348–2.671 | 0.001 |
 Pplat | 1.101 | 1.018–1.192 | 0.017 |
 CVP | 1.083 | 0.992–1.182 | 0.074 |
 TAPSE | 0.269 | 0.144–0.502 | < 0.001 |
 PASP | 1.047 | 1.018–1.077 | 0.001 |
 TAPSE/PASP | 0.006 | 0.001–0.044 | < 0.001 |
 RVOT-FS | 0.980 | 0.956–1.004 | 0.096 |
 MAPSE | 0.350 | 0.141–0.870 | 0.024 |
 LVEF | 0.987 | 0.965–1.009 | 0.239 |
 e’ | 0.882 | 0.792–0.982 | 0.022 |
Multivariable analysis 1 | |||
 LVEF | 1.019 | 0.985–1.055 | 0.272 |
 APACHEII | 1.064 | 1.008–1.123 | 0.025 |
 PASP | 1.046 | 1.012–1.081 | 0.008 |
 TAPSE | 0.248 | 0.083–0.741 | 0.013 |
Multivariable analysis 2 | |||
 LVEF | 1.018 | 0.986–1.051 | 0.271 |
 APACHEII | 1.058 | 1.006–1.113 | 0.029 |
 SOFA | 1.168 | 1.027–1.327 | 0.018 |
 TAPSE/PASP | 0.007 | 0.000–0.162 | 0.002 |